Einige der derzeit besten Biotechnology Aktien: Vertex Pharmaceuticals Inc (VRTX -1.19%), Moderna, Inc. Common Stock (MRNA -6.55%), Regeneron Pharmaceuticals Inc (REGN -2.98%), argenx SE American Depositary Shares (ARGX -3.93%).
Die folgende Tabelle zeigt insgesamt 596 Biotechnology Aktien, von denen jede zur Landschaft der Biotechnology-Branche beiträgt. Sie können die Tabelle ganz einfach anpassen, indem Sie Aktien nach Preis, Volumen oder Marktkapitalisierung entsprechend Ihren spezifischen Anlagepräferenzen ordnen.
Symbol | Firmenname | Preis | Marktkapitalisierung | Volumen | % (1D) | % (1M) | % (6M) | |
|---|---|---|---|---|---|---|---|---|
 Vertex Pharmaceuticals Inc | $542.50 | 137.54B | 2.45M | -1.19% | +7.75% | +27.84% | ||
 Moderna, Inc. Common Stock | $241.46 | 96.40B | 11.89M | -6.55% | +18.82% | +416.93% | ||
 Regeneron Pharmaceuticals Inc | $902.90 | 93.40B | 1.40M | -2.98% | +24.29% | +28.57% | ||
 argenx SE American Depositary Shares | $894.77 | 56.27B | 399.70K | -3.93% | -1.98% | +12.59% | ||
 BeOne Medicines Ltd. American Depositary Shares | $387.25 | 43.81B | 957.20K | +2.51% | +7.08% | +30.17% | ||
 Revolution Medicines, Inc. Common Stock | $177.65 | 38.08B | 7.77M | -11.04% | -14.46% | +20.68% | ||
 Genmab A/S ADS | $52.74 | 32.43B | 4.40M | -4.32% | +37.06% | +91.64% | ||
 Royalty Pharma plc Class A Ordinary Shares | $67.57 | 30.09B | 4.90M | +0.01% | +19.26% | +33.96% | ||
 Roivant Sciences Ltd. Common Shares | $36.62 | 26.45B | 9.68M | -4.21% | +2.35% | +29.31% | ||
 Incyte Genomics Inc | $118.01 | 24.05B | 1.60M | -3.94% | +3.40% | +21.07% | ||
 Insmed, Inc. | $108.76 | 23.86B | 2.62M | -1.13% | +4.75% | -22.00% | ||
 BioNTech SE American Depositary Share | $85.86 | 21.29B | 1.19M | -5.34% | -12.06% | -10.09% | ||
 Alnylam Pharmaceuticals, Inc. | $156.66 | 20.98B | 3.28M | -2.74% | -28.76% | -47.97% | ||
 Exelixis Inc | $68.71 | 16.77B | 4.60M | -5.55% | +16.75% | +54.68% | ||
 Ascendis Pharma A/S Ordinary Share | $253.45 | 16.68B | 558.07K | -1.74% | +11.15% | +12.50% | ||
 Jazz Pharmaceuticals, Inc. | $227.32 | 14.59B | 671.00K | -3.13% | -3.69% | +7.10% | ||
 BridgeBio Pharma, Inc. Common Stock | $74.27 | 14.47B | 3.39M | -4.65% | +12.29% | +7.98% | ||
 Halozyme Therapeutics, Inc. | $122.96 | 13.96B | 2.85M | -5.66% | +13.53% | +86.67% | ||
 Bio-Techne Corp. | $72.66 | 11.41B | 4.52M | -0.10% | +0.11% | +28.19% | ||
 Summit Therapeutics Inc. Common Stock | $14.19 | 11.32B | 5.95M | -12.24% | -17.83% | -19.10% | ||
 Kymera Therapeutics, Inc. Common Stock | $128.12 | 10.94B | 1.71M | -5.97% | +16.63% | +54.90% | ||
 BioMarin Pharmaceuticals Inc | $56.12 | 10.87B | 2.04M | -1.77% | -2.47% | +5.41% | ||
 Vaxcyte, Inc. Common Stock | $61.92 | 9.75B | 1.84M | -5.72% | -16.12% | +11.29% | ||
 Madrigal Pharmaceuticals, Inc. Common Stock | $400.10 | 9.29B | 859.74K | -0.08% | -18.95% | -20.37% | ||
 Spyre Therapeutics, Inc. Common Stock | $96.59 | 9.17B | 1.14M | -2.47% | +4.17% | +36.02% | ||
 Krystal Biotech, Inc. Common Stock | $300.25 | 8.90B | 401.55K | -3.41% | -10.33% | +5.51% | ||
 TG Therapeutics, Inc. | $57.98 | 8.87B | 2.11M | -5.92% | +7.55% | +60.61% | ||
 Protagonist Therapeutics, Inc | $135.26 | 8.75B | 583.89K | -5.66% | -3.82% | +36.34% | ||
 ImmunityBio, Inc. Common Stock | $8.01 | 8.49B | 12.52M | -10.30% | -22.83% | +5.67% | ||
 ARROWHEAD PHARMACEUTICALS, INC. | $57.46 | 8.12B | 1.81M | -6.80% | -7.84% | -23.32% | ||
 Twist Bioscience Corporation Common Stock | $120.61 | 8.00B | 3.06M | -15.41% | -41.17% | +112.72% | ||
 Corcept Therapeutics Inc. | $71.63 | 7.74B | 1.51M | -9.58% | -41.30% | +39.55% | ||
 Cytokinetics Inc. | $55.55 | 7.72B | 6.78M | -12.66% | -11.40% | -27.94% | ||
 Abivax SA American Depositary Shares | $84.18 | 7.37B | 1.23M | -5.94% | -8.24% | -32.00% | ||
 Caris Life Sciences, Inc. Common Stock | $26.03 | 7.36B | 7.83M | -21.64% | -14.35% | +37.36% | ||
 Praxis Precision Medicines, Inc. Common Stock | $262.59 | 7.33B | 313.85K | -7.80% | -7.40% | -21.22% | ||
 Rhythm Pharmaceuticals, Inc. Common Stock | $105.02 | 7.28B | 6.13M | -5.11% | +13.60% | +13.77% | ||
 Axsome Therapeutics, Inc | $129.80 | 6.83B | 1.11M | -5.26% | -26.70% | -41.81% | ||
 Ionis Pharmaceuticals, Inc. Common Stock | $38.80 | 6.45B | 2.97M | -3.36% | -10.80% | -48.44% | ||
 Oruka Therapeutics, Inc. Common Stock | $96.02 | 6.36B | 847.30K | -5.32% | +13.79% | +39.26% | ||
 Mirum Pharmaceuticals, Inc. Common Stock | $93.54 | 6.07B | 865.75K | -3.54% | +14.87% | -11.60% | ||
 Ligand Pharmaceuticals Inc. | $299.00 | 5.98B | 247.83K | -5.42% | -2.53% | +28.71% | ||
 Immunovant, Inc. Common Stock | $28.39 | 5.86B | 1.12M | -5.05% | -14.62% | +1.98% | ||
 Belite Bio, Inc American Depositary Shares | $143.19 | 5.77B | 223.68K | -7.03% | -10.05% | -7.25% | ||
 CG Oncology, Inc. Common stock | $64.80 | 5.74B | 931.81K | -4.30% | -5.69% | -3.54% | ||
 Kodiak Sciences Inc Common Stock | $91.02 | 5.72B | 1.10M | -7.60% | -2.97% | +113.36% | ||
 Scholar Rock Holding Corporation Common Stock | $45.50 | 5.54B | 1.45M | -1.28% | +4.84% | -3.47% | ||
 PTC Therapeutics, Inc. | $65.67 | 5.49B | 1.23M | -4.78% | +3.17% | +0.97% | ||
 Veradermics, Incorporated | $128.60 | 5.37B | 788.04K | -5.79% | +8.19% | +12.02% | ||
 Cogent Biosciences, Inc. Common Stock | $29.58 | 5.13B | 2.73M | -6.07% | -4.18% | -20.01% | ||
 CRISPR Therapeutics AG | $48.56 | 4.71B | 1.93M | -6.21% | -15.31% | -7.29% | ||
 Travere Therapeutics, Inc. Common Stock | $48.87 | 4.69B | 2.18M | -6.77% | -15.26% | +9.08% | ||
 Dianthus Therapeutics, Inc. Common Stock | $83.01 | 4.64B | 1.06M | -3.26% | -5.71% | -8.01% | ||
 Erasca, Inc. Common Stock | $13.27 | 4.64B | 6.70M | -11.00% | -9.85% | +32.83% | ||
 Legend Biotech Corporation American Depositary Shares | $22.54 | 4.38B | 3.23M | -1.01% | +20.05% | -20.94% | ||
 Edgewise Therapeutics, Inc. Common Stock | $38.87 | 4.22B | 5.05M | +3.57% | -3.55% | +2.26% | ||
 Definium Therapeutics, Inc. Common Shares | $30.36 | 4.08B | 1.92M | -7.16% | -16.20% | +35.54% | ||
 Relay Therapeutics, Inc. Common Stock | $17.00 | 3.73B | 4.73M | -5.71% | -12.33% | +30.77% | ||
 Acadia Pharmaceuticals Inc. | $21.24 | 3.66B | 6.03M | -1.07% | +5.62% | -4.97% | ||
 Xenon Pharmaceuticals Inc | $37.68 | 3.65B | 1.04M | -3.85% | +0.29% | -34.71% | ||
 AbCellera Biologics Inc. Common Shares | $11.13 | 3.61B | 4.06M | -9.36% | -19.23% | +138.84% | ||
 Tango Therapeutics, Inc. | $20.87 | 3.52B | 3.41M | -9.97% | -9.58% | -13.76% | ||
 Iovance Biotherapeutics, Inc. Common Stock | $7.74 | 3.51B | 23.34M | -11.03% | -45.30% | +94.47% | ||
 Disc Medicine, Inc. Common Stock | $78.47 | 3.48B | 931.02K | -5.78% | +23.91% | +16.10% | ||
 Parabilis Medicines, Inc. Common Stock | $27.88 | 3.44B | 922.42K | -8.17% | -5.59% | 0.00% | ||
 Arcutis Biotherapeutics, Inc. Common Stock | $27.00 | 3.39B | 7.61M | -20.70% | +7.36% | +15.29% | ||
 Tarsus Pharmaceuticals, Inc. Common Stock | $67.52 | 3.33B | 1.61M | -2.24% | -9.31% | +3.81% | ||
 Viking Therapeutics, Inc | $25.79 | 3.29B | 4.81M | -7.79% | -11.92% | -17.63% | ||
 Enliven Therapeutics, Inc. Common Stock | $44.79 | 3.28B | 1.61M | -5.21% | -1.50% | +7.72% | ||
 Viridian Therapeutics, Inc. Common Stock | $28.55 | 3.24B | 3.44M | -1.74% | +50.26% | +52.27% | ||
 Dyne Therapeutics, Inc. Common Stock | $17.36 | 3.24B | 3.21M | -6.36% | +12.44% | -0.63% | ||
 Telix Pharmaceuticals Limited American Depositary Shares | $9.42 | 3.20B | 328.16K | -2.59% | -13.42% | -14.67% | ||
 Denali Therapeutics Inc. Common Stock | $19.72 | 3.16B | 2.25M | -5.92% | -0.95% | +4.23% | ||
 Celcuity Inc. Common Stock | $64.04 | 3.13B | 1.10M | -7.51% | -13.01% | -54.80% | ||
 IDEAYA Biosciences, Inc. Common Stock | $30.65 | 2.96B | 1.24M | -5.28% | -19.47% | +6.42% | ||
 ADMA Biologics, Inc. | $13.21 | 2.96B | 15.02M | +26.05% | +30.66% | +28.88% | ||
 Zai Lab Limited American Depositary Shares | $22.60 | 2.81B | 815.55K | -0.88% | -11.79% | +7.72% | ||
 Beam Therapeutics Inc. Common Stock | $25.87 | 2.68B | 2.99M | -6.91% | +0.78% | -10.48% | ||
 Vericel Corporation | $51.78 | 2.65B | 2.68M | +13.85% | +26.08% | +40.67% | ||
 Xencor, Inc. | $34.05 | 2.53B | 1.43M | -2.80% | +32.85% | +164.98% | ||
 MBX Biosciences, Inc. Common Stock | $48.46 | 2.33B | 428.65K | -7.66% | -17.22% | +63.72% | ||
 Pharvaris N.V. Ordinary Shares | $32.53 | 2.28B | 907.15K | -5.24% | +6.69% | +8.36% | ||
 NewAmsterdam Pharma Company N.V. Ordinary Shares | $18.89 | 2.27B | 1.56M | -9.75% | -17.15% | -36.72% | ||
 Palvella Therapeutics, Inc. Common Stock | $156.85 | 2.26B | 269.78K | -3.35% | +18.68% | +21.15% | ||
 Arcus Biosciences, Inc. | $17.69 | 2.25B | 2.03M | -8.39% | -28.50% | -32.12% | ||
 Celldex Therapeutics, Inc | $28.27 | 2.22B | 1.11M | -5.55% | -13.26% | -16.51% | ||
 Lakefront Biotherapeutics American Depositary Shares | $33.56 | 2.21B | 343.08K | -1.55% | +13.72% | 0.00% | ||
 Septerna, Inc. Common Stock | $47.35 | 2.21B | 533.23K | -1.11% | +25.03% | +96.23% | ||
 Recursion Pharmaceuticals, Inc. Class A Common Stock | $3.50 | 2.18B | 25.26M | -9.79% | -26.78% | +3.86% | ||
 Aurinia Pharmaceuticals Inc | $16.21 | 2.17B | 1.14M | -5.26% | +3.12% | +1.06% | ||
 Vera Therapeutics, Inc. Class A Common Stock | $30.14 | 2.17B | 1.41M | -5.72% | +1.04% | -12.69% | ||
 Hemab Therapeutics Holdings, Inc. Common Stock | $45.57 | 2.13B | 456.91K | +1.06% | +48.97% | +82.28% | ||
 Immunome, Inc. | $17.91 | 2.11B | 2.21M | -8.27% | -15.42% | -22.52% | ||
 Biohaven Ltd. | $13.90 | 2.10B | 3.47M | -8.79% | +7.17% | +43.15% | ||
 Zymeworks Inc. | $28.74 | 2.07B | 1.22M | -7.13% | +9.63% | +7.70% | ||
 Fortrea Holdings Inc. Common Stock | $20.46 | 1.97B | 2.41M | -1.78% | -3.08% | +40.81% | ||
 First Tracks Biotherapeutics, Inc. Ordinary Shares | $45.43 | 1.91B | 570.37K | -7.36% | +37.71% | +114.39% | ||
 Harmony Biosciences Holdings, Inc. Common Stock | $32.47 | 1.91B | 1.48M | -5.65% | -18.66% | +0.40% | ||
 Replimune Group, Inc. | $20.02 | 1.90B | 4.00M | -3.24% | +52.24% | +597.56% | ||
 Vir Biotechnology, Inc. Common Stock | $11.02 | 1.86B | 2.93M | -6.37% | -6.45% | +10.09% | ||
 Sarepta Therapeutics,, Inc. Common Stock | $17.57 | 1.86B | 1.86M | -7.48% | +0.46% | -19.37% | ||
 Mesoblast Limited American Depositary Shares | $14.10 | 1.83B | 258.28K | -1.33% | -0.84% | -10.70% | ||
 Trevi Therapeutics, Inc. Common Stock | $12.81 | 1.83B | 1.58M | -8.40% | -6.63% | -12.62% | ||
 Maze Therapeutics, Inc. Common Stock | $32.53 | 1.81B | 643.89K | -2.55% | +23.08% | +22.48% | ||
 Zenas BioPharma, Inc. Common Stock | $25.93 | 1.69B | 822.61K | -8.89% | -6.83% | +24.90% | ||
 Stoke Therapeutics, Inc. Common Stock | $26.07 | 1.69B | 1.22M | -5.03% | +2.96% | -20.90% | ||
 Agios Pharmaceuticals, Inc. | $28.27 | 1.69B | 2.55M | -9.91% | -9.54% | +3.90% | ||
 Nurix Therapeutics, Inc. Common stock | $14.84 | 1.62B | 6.24M | -6.96% | -35.14% | -10.60% | ||
 Generate Biomedicines, Inc. Common Stock | $12.57 | 1.61B | 1.30M | -11.23% | -9.63% | -18.48% | ||
 Novavax Inc | $9.78 | 1.61B | 8.21M | -8.17% | -22.13% | +20.74% | ||
 Absci Corporation Common Stock | $9.39 | 1.61B | 5.12M | -10.40% | -18.56% | +67.38% | ||
 SELLAS Life Sciences Group, Inc. Common Stock | $7.88 | 1.59B | 10.69M | -13.79% | -32.24% | +61.81% | ||
 Ultragenyx Pharmaceutical Inc. | $15.57 | 1.59B | 5.38M | -9.27% | +7.38% | -37.74% | ||
 Kailera Therapeutics, Inc. Common Stock | $12.17 | 1.58B | 845.96K | -4.92% | +12.27% | -49.84% | ||
 Braveheart Bio, Inc. Common Stock | $17.42 | 1.57B | 1.59M | -13.38% | -18.43% | 0.00% | ||
 Intellia Therapeutics, Inc | $11.10 | 1.56B | 7.60M | -9.83% | -12.94% | -16.60% | ||
 Nanobiotix S.A. American Depositary Shares | $30.02 | 1.53B | 567.46K | +1.08% | +19.60% | -13.66% | ||
 Precigen, Inc. Common Stock | $4.22 | 1.51B | 26.69M | -16.52% | -45.48% | -2.54% | ||
 Lycia Therapeutics, Inc. Common Stock | $28.80 | 1.50B | 190.15K | -0.41% | 0.00% | 0.00% | ||
 uniQure N.V. | $21.01 | 1.47B | 3.94M | -8.77% | -7.85% | -0.71% | ||
 Nuvation Bio Inc. | $4.19 | 1.47B | 8.42M | -11.42% | -15.35% | -13.25% | ||
 Immunocore Holdings plc American Depositary Shares | $28.40 | 1.46B | 372.28K | -2.84% | -4.02% | -1.53% | ||
 Tyra Biosciences, Inc. Common Stock | $20.89 | 1.44B | 696.02K | -2.95% | -0.19% | -38.43% | ||
 ADARx Pharmaceuticals, Inc. Common Stock | $13.29 | 1.42B | 781.21K | -11.16% | -30.24% | -47.98% | ||
 Ascentage Pharma Group International American Depository Shares | $15.13 | 1.41B | 9,864 | +0.40% | +3.59% | -30.91% | ||
 Ocular Therapeutix, Inc. | $6.43 | 1.41B | 3.13M | -9.94% | -11.31% | -33.78% | ||
 Rapport Therapeutics, Inc. Common Stock | $23.72 | 1.41B | 707.46K | -8.52% | -26.31% | -33.35% | ||
 Innoviva, Inc. Common Stock | $19.24 | 1.39B | 2.65M | -9.50% | -6.78% | -15.06% | ||
 Korsana Biosciences, Inc. Common Stock | $30.43 | 1.39B | 110.23K | -0.43% | -0.94% | 0.00% | ||
 AnaptysBio, Inc. Common Stock | $45.58 | 1.36B | 381.49K | -4.06% | -7.36% | -34.21% | ||
 Structure Therapeutics Inc. American Depositary Shares | $19.08 | 1.36B | 1.01M | -6.29% | -30.84% | -53.58% | ||
 Damora Therapeutics, Inc. Ordinary Shares | $21.86 | 1.35B | 793.81K | -4.71% | +8.11% | -12.10% | ||
 Mineralys Therapeutics, Inc. Common Stock | $15.24 | 1.35B | 2.56M | -10.35% | -34.59% | -47.95% | ||
 Taysha Gene Therapies, Inc. Common Stock | $4.09 | 1.33B | 6.75M | -6.19% | -8.91% | -41.07% | ||
 Kardigan, Inc. Common Stock | $13.86 | 1.30B | 676.25K | -10.93% | -9.06% | 0.00% | ||
 GH Research PLC Ordinary Shares | $18.44 | 1.27B | 407.74K | -7.48% | -16.82% | -13.35% | ||
 UroGen Pharma Ltd. Ordinary Shares | $25.73 | 1.26B | 2.43M | -10.47% | -39.86% | +7.97% | ||
 Omeros Corporation | $17.07 | 1.24B | 991.87K | -6.11% | -9.68% | +15.57% | ||
 Nektar Therapeutics | $36.15 | 1.23B | 710.61K | -6.06% | -14.38% | -57.05% | ||
 Alpha Tau Medical Ltd. Ordinary Shares | $13.30 | 1.23B | 674.43K | -5.20% | -10.68% | +79.97% | ||
 LB Pharmaceuticals Inc Common Stock | $38.09 | 1.23B | 354.42K | -6.76% | +10.02% | +15.85% | ||
 Silence Therapeutics Plc American Depository Share | $19.72 | 1.23B | 1.40M | -0.40% | +94.48% | +176.19% | ||
 Mannkind Corporation | $3.76 | 1.21B | 5.40M | -4.33% | -1.57% | +31.47% | ||
 Avalyn Pharma Inc. Common Stock | $26.67 | 1.18B | 476.72K | -2.91% | -1.33% | -2.77% | ||
 Inhibrx Biosciences, Inc. Common Stock | $80.28 | 1.18B | 242.41K | -7.47% | -15.10% | -37.34% | ||
 Vor Biopharma Inc. Common Stock | $18.66 | 1.15B | 629.77K | -7.26% | +0.43% | +20.23% | ||
 SpyGlass Pharma, Inc. Common Stock | $34.08 | 1.14B | 192.28K | -1.07% | +33.18% | +39.61% | ||
 Verastem, Inc. | $9.38 | 1.14B | 3.03M | -4.77% | +17.25% | +57.38% | ||
 Seaport Therapeutics, Inc. Common Stock | $20.39 | 1.09B | 221.06K | -2.72% | +10.22% | +27.44% | ||
 Maravai LifeSciences Holdings, Inc. Class A Common Stock | $6.98 | 1.04B | 3.22M | -9.59% | -18.08% | +81.30% | ||
 Janux Therapeutics, Inc. Common Stock | $16.06 | 981.86M | 892.95K | -11.66% | -2.90% | +12.07% | ||
 Immatics N.V. Ordinary Shares | $6.18 | 940.75M | 1.28M | -10.56% | -20.05% | -43.56% | ||
 MoonLake Immunotherapeutics Class A Ordinary Shares | $10.80 | 919.15M | 1.32M | -6.57% | -5.10% | -36.51% | ||
 Odyssey Therapeutics, Inc. Common Stock | $18.88 | 907.52M | 434.53K | -3.18% | -9.40% | 0.00% | ||
 Savara Inc. | $4.38 | 899.91M | 3.45M | -6.01% | -8.37% | -16.57% | ||
 Jade Biosciences, Inc. Common Stock | $14.10 | 896.72M | 1.29M | -6.25% | +0.21% | -44.18% | ||
 Oric Pharmaceuticals, Inc. Common Stock | $8.49 | 880.01M | 1.39M | -9.10% | -32.03% | -11.29% | ||
 Monte Rosa Therapeutics, Inc. Common Stock | $10.25 | 874.46M | 1.50M | -5.27% | -0.19% | -47.03% | ||
 Pharming Group N.V. ADS, each representing 10 ordinary shares | $12.30 | 870.57M | 12,507 | -1.28% | +25.51% | -23.93% | ||
 Latigo Biotherapeutics, Inc. Common Stock | $13.01 | 862.55M | 424.86K | -7.34% | -21.77% | 0.00% | ||
 City Therapeutics, Inc. Common Stock | $17.07 | 859.17M | 210.24K | +4.02% | 0.00% | 0.00% | ||
 Alto Neuroscience Inc. | $21.87 | 858.22M | 411.27K | -6.14% | -8.91% | -14.07% | ||
 Inventiva S.A. American Depository Shares | $3.63 | 857.53M | 2.54M | -6.20% | +4.31% | -33.03% | ||
 Rigel Pharmaceuticals Inc. (New) | $45.71 | 853.86M | 553.30K | -10.88% | -4.35% | +62.73% | ||
 Syndax Pharmaceuticals, Inc. | $9.37 | 843.56M | 5.79M | -10.33% | -47.45% | -53.38% | ||
 Aktis Oncology, Inc. Common stock | $14.85 | 825.95M | 440.72K | -2.30% | -19.82% | -23.61% | ||
 Corvus Pharmaceuticals, Inc. | $9.73 | 818.50M | 1.15M | -7.95% | -9.40% | -38.03% | ||
 MeiraGTx Holdings plc Ordinary Shares | $8.51 | 817.33M | 688.57K | -9.66% | -22.07% | -12.72% | ||
 Bambusa Therapeutics, Inc. Common Stock | $15.85 | 807.44M | 421.57K | -1.37% | 0.00% | 0.00% | ||
 Prime Medicine, Inc. Common Stock | $4.45 | 807.13M | 4.75M | -10.46% | +38.63% | +31.27% | ||
 Annexon, Inc. Common Stock | $4.01 | 759.26M | 4.35M | -7.51% | -4.64% | -29.98% | ||
 Alumis Inc. Common Stock | $5.85 | 757.20M | 1.95M | -10.69% | -14.47% | -77.61% | ||
 Ardelyx, Inc. | $2.99 | 751.60M | 7.76M | -9.12% | -11.80% | -58.06% | ||
 Arbutus Biopharma Corporation Common Stock | $3.67 | 727.05M | 6.17M | -9.61% | -21.41% | -16.59% | ||
 Lexicon Pharmaceuticals, Inc. | $1.61 | 716.38M | 3.80M | +8.78% | -7.47% | -2.42% | ||
 OmniAb, Inc. Common Stock | $4.83 | 704.51M | 1.25M | -6.76% | -1.83% | +245.00% | ||
 Sana Biotechnology, Inc. Common Stock | $2.34 | 700.50M | 3.07M | -8.59% | -18.75% | -32.95% | ||
 Cullinan Therapeutics, Inc. Common Stock | $10.80 | 695.03M | 1.79M | -13.53% | -32.67% | -27.71% | ||
 Attovia Therapeutics, Inc. Common Stock | $15.00 | 684.77M | 376.78K | -3.85% | -16.64% | +3,081% | ||
 Ginkgo Bioworks Holdings, Inc. | $9.96 | 670.71M | 2.36M | -14.51% | -33.51% | +2.57% | ||
 Solid Biosciences Inc. Common Stock | $6.18 | 662.65M | 1.44M | -5.21% | -12.46% | -10.43% | ||
 Aura Biosciences, Inc. Common Stock | $6.34 | 657.49M | 791.18K | -4.66% | +1.93% | -28.76% | ||
 Achieve Life Sciences, Inc. | $6.38 | 657.28M | 1.81M | -8.67% | -9.06% | +39.80% | ||
 Sagimet Biosciences Inc. Series A Common Stock | $9.12 | 646.69M | 1.16M | -8.71% | +1.00% | +18.13% | ||
 Wave Life Sciences Ltd. Ordinary Shares | $3.22 | 635.08M | 5.33M | -11.05% | -14.13% | -55.15% | ||
 Zevra Therapeutics, Inc. Common Stock | $10.53 | 626.58M | 1.68M | -5.73% | -1.59% | -0.75% | ||
 Adlai Nortye Group Ltd. American Depositary Shares | $9.68 | 623.37M | 450.32K | +0.73% | -35.64% | -35.16% | ||
 4D Molecular Therapeutics, Inc. Common Stock | $11.25 | 621.50M | 1.60M | -8.39% | -12.93% | +15.86% | ||
 DBV Technologies S.A. American Depositary Shares | $9.80 | 615.84M | 415.48K | -1.41% | -6.13% | -49.72% | ||
 Candel Therapeutics, Inc. Common Stock | $8.04 | 615.21M | 1.23M | -11.16% | -21.41% | +4.82% | ||
 Helus Pharma Inc. | $8.39 | 613.05M | 1.43M | -3.34% | -26.53% | +60.73% | ||
 Nuvectis Pharma, Inc. Common Stock | $17.76 | 610.75M | 340.93K | -3.84% | -16.97% | +82.90% | ||
 Geron Corp | $0.9501 | 610.41M | 25.80M | -12.03% | -21.48% | -42.42% | ||
 Design Therapeutics, Inc. Common Stock | $9.67 | 605.16M | 751.93K | -9.03% | -22.14% | -27.89% | ||
 Kura Oncology, Inc. | $6.80 | 604.93M | 3.60M | -10.64% | -35.97% | -26.80% | ||
 ArriVent BioPharma, Inc. Common Stock | $12.23 | 603.03M | 1.10M | -9.34% | -57.03% | -59.00% | ||
 Immix Biopharma, Inc. Common Stock | $7.20 | 596.90M | 1.42M | -9.66% | -28.92% | -24.69% | ||
 Obsidian Therapeutics, Inc. Common Stock | $9.60 | 593.02M | 779.35K | -12.65% | -30.64% | 0.00% | ||
 Olema Pharmaceuticals, Inc. Common Stock | $6.76 | 591.48M | 1.71M | -10.34% | -18.06% | -53.83% | ||
 Apnimed, Inc. Common Stock | $14.16 | 589.49M | 447.80K | -7.45% | -34.90% | 0.00% |